Evidence map›Paper›PMID 32553709›Full record

ArticleNeurobiology of disease2020

The environmental toxicant ziram enhances neurotransmitter release and increases neuronal excitability via the EAG family of potassium channels.

Jenna Harrigan, Daisy F Brambila, Pratap Meera, David E Krantz, Felix E Schweizer

Open access · goldAbstract read
In one paragraph

Article in Neurobiology of disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Regulation ofiScience · 2022
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jenna HarriganMolecular Toxicology PhD Program, School of Public Health, University of California Los Angeles, United States of America.
Daisy F BrambilaDepartment of Neurobiology, David Geffen School of Medicine, University of California Los Angeles, United States of America.
Pratap MeeraDepartment of Neurobiology, David Geffen School of Medicine, University of California Los Angeles, United States of America.
David E KrantzMolecular Toxicology PhD Program, School of Public Health, University of California Los Angeles, United States of America; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, United States of America; Brain Research Institute, University of California Los Angeles, United States of America. Electronic address: dkrantz@ucla.edu.
Felix E SchweizerMolecular Toxicology PhD Program, School of Public Health, University of California Los Angeles, United States of America; Department of Neurobiology, David Geffen School of Medicine, University of California Los Angeles, United States of America; Brain Research Institute, University of California Los Angeles, United States of America. Electronic address: felixs@ucla.edu.
University of California, Los Angeles · US

Funding

Training in Molecular ToxicologyT32ES015457 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALLARD, PATRICK, HANKINSON, OLIVER NMN · 2008 to 2025
$4.0M
Models of Neuromodulatory Circuits in DrosophilaR01MH114017 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KRANTZ, DAVID EVAN · 2018 to 2022
$2.1M
The Influence of Neurotransmitter Transport on Aminergic NeuromodulationR01MH107390 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KRANTZ, DAVID EVAN · 2015 to 2019
$1.9M
Ubiquitination as an acute regulator of synaptic transmissionR21NS075506 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SCHWEIZER, FELIX E · 2011 to 2012
$424k
NIEHS NIH HHS T32 ES015457NIMH NIH HHS R01 MH107390NIMH NIH HHS R01 MH114017NINDS NIH HHS R21 NS075506
6 · The paper itself

Abstract

Environmental toxicants have the potential to contribute to the pathophysiology of multiple complex diseases, but the underlying mechanisms remain obscure. One such toxicant is the widely used fungicide ziram, a dithiocarbamate known to have neurotoxic effects and to increase the risk of Parkinson's disease. We have used Drosophila melanogaster as an unbiased discovery tool to identify novel molecular pathways by which ziram may disrupt neuronal function. Consistent with previous results in mammalian cells, we find that ziram increases the probability of synaptic vesicle release by dysregulation of the ubiquitin signaling system. In addition, we find that ziram increases neuronal excitability. Using a combination of live imaging and electrophysiology, we find that ziram increases excitability in both aminergic and glutamatergic neurons. This increased excitability is phenocopied and occluded by null mutant animals of the ether a-go-go (eag) potassium channel. A pharmacological inhibitor of the temperature sensitive hERG (human ether-a-go-go related gene) phenocopies the excitability effects of ziram but only at elevated temperatures. seizure (sei), a fly ortholog of hERG, is thus another candidate target of ziram. Taken together, the eag family of potassium channels emerges as a candidate for mediating some of the toxic effects of ziram. We propose that ziram may contribute to the risk of complex human diseases by blockade of human eag and sei orthologs, such as hERG.

Indexed as

AnimalsDrosophila melanogasterEther-A-Go-Go Potassium ChannelsFungicides, IndustrialHumansNeuronsNeurotransmitter AgentsSynaptic VesiclesZiramEther-A-Go-Go Potassium ChannelsFungicides, IndustrialNeurotransmitter AgentsZiramComplex diseasesE1 ligaseether-a-go-goFungicidehERGNeuronal excitabilityNeurotoxicantPesticidePotassium channelRelease probabilitysei channelSynaptic transmissionSynaptic vesicleZiram

Identifiers

PMID32553709
PMCPMC8501297
OpenAlexW3034926003

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.